Skip to main content
Premium Trial:

Request an Annual Quote

Roche Posts Flat MDx Sales

NEW YORK (GenomeWeb News) – Roche today reported flat molecular diagnostics sales for the first nine months of 2013 compared to the first nine months of 2012.

The Swiss pharmaceuticals, diagnostics, and research products firm posted overall sales of CHF 34.87 billion ($38.63 billion) for the nine months ended Sept. 30, up 3 percent from CHF 33.69 for the first nine months of 2012.

Its diagnostics sales were up 2 percent to CHF 7.68 billion from CHF 7.50 billion.

Within the Diagnostics Division, the firm's molecular diagnostics sales were flat year over year at CHF 1.19 billion, but up 2 percent at constant exchange rates. Roche said that MDx sales were driven by its human papillomavirus tests, real-time qPCR reagents, and oncology companion diagnostic tests. Growth, however, was offset by declines in the firm's sequencing business.

As reported by GenomeWeb Daily News earlier this week, Roche is shutting down its 454 Life Sciences sequencing operations and laying off about 100 employees. The firm said the 454 sequencers will be phased out by mid-2016.

Roche, however, is not exiting the genomic sequencing market. Last month it forged a deal for up to $75 million with Pacific Biosciences to develop diagnostic products based on PacBio's SMRT technology.

Sales for Roche's Pharmaceutical division climbed 4 percent year over year to CHF 27.19 billion from CHF 26.20 billion.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.